APA Citatie

Wei, A. C., Ou, F., Shi, Q., Carrero, X., O’Reilly, E. M., Meyerhardt, J., . . . Posner, M. C. (2019). Perioperative gemcitabine + erlotinib plus pancreaticoduodenectomy for resectable pancreatic adenocarcinoma: ACOSOG Z5041 (Alliance) phase II trial. Ann Surg Oncol.

Chicago Style citaat

Wei, Alice C., et al. "Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial." Ann Surg Oncol 2019.

MLA citatie

Wei, Alice C., et al. "Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial." Ann Surg Oncol 2019.